Valuation: PharmaCorp Rx Inc.

Market Cap 7.98Cr 5.7Cr 5.08Cr 4.65Cr 4.23Cr 538.81Cr 8.19Cr 56Cr 22Cr 285.35Cr 21Cr 21Cr 900.44Cr P/E 2026 *
40.5x
P/E 2027 * 13.5x
Enterprise Value 8.64Cr 6.17Cr 5.5Cr 5.03Cr 4.58Cr 583.41Cr 8.87Cr 60Cr 24Cr 308.97Cr 23Cr 23Cr 974.97Cr EV / Sales 2026 *
1.73x
EV / Sales 2027 * 0.91x
Free-Float
91.69%
Yield 2026 *
-
Yield 2027 * -
1 week-1.22%
Current month+1.25%
1 month-1.22%
3 months-17.35%
6 months-22.12%
Current year-10.99%
1 week 0.38
Extreme 0.385
0.42
1 month 0.38
Extreme 0.375
0.44
Current year 0.38
Extreme 0.375
0.58
1 year 0.38
Extreme 0.375
0.58
3 years 0.38
Extreme 0.375
0.88
5 years 0.12
Extreme 0.12
0.88
10 years 0.12
Extreme 0.12
0.88
Date Insider Type Main position Quantity % Market Cap. Importance
14/07/26 Buy

Chief Executive Officer

1,72,942 0.0993%
14/07/26 Buy

Founder

1,73,333 0.0996%
14/07/26 Buy

Chairperson

1,73,333 0.0996%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.22%-15.62%+92.86% 5.71Cr
-0.83%+12.55%-29.70%+10.66% 1.63TCr
-4.07%+5.52%-10.69%+8.78% 666.26Cr
-2.97%+2.94%-4.64%+2.09% 652.57Cr
-0.95%+10.27%-45.64%-37.45% 608.83Cr
-19.95%-5.23%-25.82%-40.94% 491.2Cr
-0.07%+5.87%+14.11%-10.52% 484.86Cr
+1.12%+12.49%+12.00%-16.99% 349.53Cr
+2.54%+1.97%-17.70%-30.60% 314.13Cr
+3.76%+9.35%-35.50%-20.05% 311.66Cr
Average -2.14%+3.51%-15.92%-4.22% 551.33Cr
Weighted average by Cap. -2.54%+5.65%-18.99%-8.11%

Financials

2026 *2027 *
Net sales 5Cr 3.57Cr 3.18Cr 2.91Cr 2.65Cr 337.43Cr 5.13Cr 35Cr 14Cr 178.7Cr 13Cr 13Cr 563.91Cr 9.6Cr 6.86Cr 6.11Cr 5.59Cr 5.09Cr 648.18Cr 9.86Cr 67Cr 27Cr 343.27Cr 26Cr 25Cr 1.08TCr
Net income 15L 10.72L 10L 9L 8L 10Cr 15.4L 1.05Cr 41.98L 5.37Cr 40.24L 39.38L 17Cr 67L 47.88L 42.67L 39.03L 35.54L 45Cr 68.81L 4.69Cr 1.87Cr 24Cr 1.8Cr 1.76Cr 76Cr
Net Debt 66.03L 47.19L 42.05L 38.46L 35.03L 45Cr 67.81L 4.62Cr 1.85Cr 24Cr 1.77Cr 1.73Cr 75Cr 74.51L 53.25L 47.45L 43.4L 39.53L 50Cr 76.52L 5.21Cr 2.09Cr 27Cr 2Cr 1.96Cr 84Cr
Projected Income Statement - Annual - PharmaCorp Rx Inc.
Logo PharmaCorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The Company operates approximately 17 PharmaChoice Canada-bannered pharmacies. It focuses on acquiring both PharmaChoice Canada bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its strategic alliance with PharmaChoice Canada.
Employees
-
Date Price Change Volume
05/26/05 CA$0.4050 0.00% 1,04,362
04/26/04 CA$0.4050 -1.22% 12,600
03/26/03 CA$0.4100 0.00% 30,600
02/26/02 CA$0.4100 +2.50% 1,170
30/26/30 CA$0.4000 -2.44% 2,822
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - PharmaCorp Rx Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4050CAD
Average target price
0.6667CAD
Spread / Average Target
+64.61%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PharmaCorp Rx Inc.
  1. Stock Market
  2. Stocks
  3. PCRX Stock